A new study has identified a potential method to control the Epstein-Barr virus (EBV), a common herpesvirus carried by an estimated 95% of the global adult population. While often asymptomatic, EBV is linked to several serious conditions, including multiple sclerosis and certain cancers. The research focused on a specific viral protein, EBNA1, which is crucial for the virus’s ability to persist and replicate in human cells. Scientists discovered a compound that can inhibit this protein’s function, effectively blocking viral replication in laboratory models. This finding represents a significant step toward developing targeted therapies that could suppress the virus and potentially prevent or treat the diseases associated with it. Read the full article at: https://www.sciencedaily.com/releases/2026/04/260414075650.htm